In this episode of The Open Loop, Chay Carter is joined by Adam Fraser, Chief Operating Officer at Omniscient Neurotechnology.
Adam shares how Omniscient is taking connectomics out of the lab and into clinical practice, using AI and MRI data to help decode the brain’s structural and functional networks.
We explore how connectomics can support neurosurgical planning today, why brain network mapping could become important across DBS, stroke, coma, epilepsy and psychiatry, and what it takes to build a scalable neurotechnology platform inside the US healthcare system.
Adam also discusses Omniscient’s go-to-market journey, reimbursement, medical education, the company’s US focus, the role of AI in brain mapping, and why mental health remains a long-term North Star for the business.
Key takeaways:
🔹 What connectomics means and why it matters for brain health
🔹 How structural and functional connectomes act like “roads and traffic” for the brain
🔹 Why neurosurgical planning was Omniscient’s first major clinical focus
🔹 How connectomics could support future work in DBS, stroke, coma, epilepsy and psychiatry
🔹 Why bringing new neurotechnology into the US healthcare system requires evidence, reimbursement and medical education
Host: Chay Carter
Founder, Carter Sciences | Co-Founder, Reccy Neuro
LinkedIn: https://www.linkedin.com/in/chay-carter/
Guest: Adam Fraser
Chief Operating Officer, Omniscient Neurotechnology
LinkedIn: https://www.linkedin.com/in/adam-fraser-23202133/
The Open Loop is a podcast exploring the people, companies, and ideas shaping the future of neurotechnology.
🔔 Subscribe for weekly conversations with the founders, researchers, operators, and industry leaders building what comes next in brain health, medicine, and technology.
If you enjoyed this episode, please subscribe, leave a review, and share it with someone interested in neurotechnology.
New episodes of The Open Loop drop weekly.
Sponsor:
This episode is sponsored by Reccy Neuro — the home of neurotech. Jobs, companies, investors, events, Cortex industry intelligence, and specialist resources for the neurotech market.
Learn more about Reccy Neuro here: https://neuro.reccy.dev/
